Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-14

Clinical Trial Update: The Effect of Aromatherapy on Neonatal Abstinence Syndrome and Salivary Cortisol Levels [Phase 3]

View source ↗

Summary

Phase 3 trial investigating aromatherapy for neonatal abstinence syndrome and its effects on salivary cortisol; study completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: John M. Daniel | Conditions: Neonatal Abstinence Syndrome, Aromatherapy | Phase 3 | Status: COMPLETED | Results posted: 2019-05-14